The global cannabis market is still in the early innings of a multi-year boom.

Thanks in large part to growing acceptance of cannabis - including Canada's legalization in October 2018, further U.S. state approval, and growing interest from corporate America the global market is expected to reach $146.4 billion by 2025, according to Grand View Research Inc. from $7.06 billion in 2016.

In addition, the growing adoption of cannabis in medical applications such as cancer, mental disorders, and chronic pain is expected to propel revenue growth even more. As millions of people living all over the world look to embrace its medicinal properties, marijuana companies are quickly gaining the attention of cannabis investors.

As cannabis just begins to gain momentum, several companies are experiencing sizable growth and opportunities, including Pure Global Cannabis Inc. (CSE: PURE) (OTC PINK: PRCNF), Tilray Inc. (NASDAQ: TLRY), and CannTrust Holdings Inc. (TSX: TRST)(OTC:CNTTF).

Pure Global Cannabis'(PURE)(PRCNF) subsidiary, PureSinse Inc. is launching its PureSinse.com e-store following receipt of its Sales License from Health Canada in January 2019. The online store is ready to service physicians and register medical cannabis patients from across Canada who hold a valid medical document.

"We are excited to open our PureSinse e-store and start servicing the medical community which we feel his hugely underserviced," says Malay Panchal, President and CEO of Pure Global. "Our site is robust, user-friendly, easy to navigate, and we have many patients already pre-registered. It offers an optimal user experience, with enhancements to follow that will offer more education and clinical material. We are working towards servicing thousands of patients by year end," added Mr. Panchal.

As a Health Canada approved licensed producer, PureSinse will continue to add quality cannabis products to the eStore as they become available. Currently the company is licensed to sell dried flower and will be adding oils and oil derivative products upon receiving Health Canada approvals. PureSinse products are made with sustainable and recyclable packaging, and strive to adopt sustainable methods throughout its production, processing, operating, and packaging methodology. Registered patients will receive expedited delivery and free home shipping for purchases over $100 CAD.

Tilray Inc. (TLRY) just announced plans to acquire Natura Naturals for $52.45 million, which will double its Canadian cultivation capacity, notes Bloomberg. The deal includes Natura's 662,000 sq. ft. greenhouse, including 155,000 sq. ft. that is currently licensed.

"We're very pleased to have an agreement in place that allows us to expand our capacity to supply high-quality branded cannabis products to the Canadian market. Through an extensive and thorough search for the right supply partner, we're pleased to have come to a mutually-beneficial agreement with Natura," said President and CEO, Brendan Kennedy.

CannTrust Holdings (CNTTF)(TRST) produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. It also serves up to 50,000 active patients at this time.

In addition, over the last few weeks, the company applied to list its shares on the NYSE.

"CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in trust, science and innovation," CannTrust CEO Peter Aceto said. "A listing on the NYSE is a natural step forward in our evolution as we look to broaden our investor base, increase the company's exposure and expand our business on an international scale."

Better yet, the company is targeting 100,000 kilograms of annual production capacity. Should it deliver on that target, it would be among the biggest Canadian marijuana stocks.